admedus, page-22

Love your thinking. Unfortunately ethics committees might not approve.

Unless I am missing your sarcasm. They are currently conducting Phase I/II trials, so these are in healthy human patients. Terry I think you're very eager, but I would suggest extending your timeframes by a few months/years for anything definitive on the Herpes immunisation. Whilst you might see a response in days, you would want to see long term coverage.

The next bump on SP might come with FDA, although I would suspect that might have been taken into consideration on the valuation. It will be interesting to see if we some information on sales from Europe on a 6month cycle.